Dexco revenue and financials
R$6.86Change from previous close: +0.73%Absolute change: +R$0.05
In the fiscal year ended December 2025, Dexco reported revenue of R$8.25B (+0.17% year over year). Net income was R$1.18M, a net margin of 0.0%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +0.17%
- 2025 vs 2024
- Net income growth
- −99.31%
- 2025 vs 2024
- Net margin
- 0.0%
- 2024: 2.1%
Financial data
Amounts in millions of BRL; per-share values in BRL; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 291 | 476 | 311 | 257 | 253 | 30.0 | 412 | 408 | 390 | 73.5 | 611 | 366 |
| Depreciation and amortization | 387 | 323 | 291 | 273 | 390 | 287 | 270 | 306 | 345 | 278 | 326 | 246 |
| Capital expenditure | -243 | -153 | -328 | -189 | -222 | -172 | -362 | -288 | -419 | -260 | -417 | -310 |
| Investing cash flow | -105 | -178 | -316 | 159 | -509 | -105 | -394 | -717 | -521 | -349 | -389 | -340 |
| Financing cash flow | -612 | 296 | 961 | -73.2 | 31.0 | -60.1 | -497 | -57.7 | -634 | 306 | 945 | 100 |
| Dividends paid | -62.9 | — | -43.4 | -2.2 | — | — | -234 | -0.0 | -0.0 | — | -0.0 | -0.0 |
| Debt issued | 0.0 | 293 | 2,943 | — | 498 | 0.0 | 0.2 | — | 38.1 | 375 | 1,454 | — |
| Debt repaid | -544 | -158 | -2,025 | -40.7 | -437 | -37.5 | -428 | -35.2 | -636 | -35.5 | -437 | -31.3 |
| Effect of exchange rates | 21.9 | -8.4 | 20.0 | -2.4 | -34.2 | 24.0 | 16.4 | -5.9 | 7.8 | 7.1 | 0.8 | 6.5 |
| Net change in cash | -404 | 586 | 976 | 341 | -259 | -111 | -462 | -372 | -757 | 37.3 | 1,167 | -29.6 |
| Free cash flow | 47.7 | 324 | -17.3 | 68.6 | 30.8 | -142 | 49.7 | 121 | -28.8 | -186 | 194 | 55.5 |
| Levered free cash flow | -61.2 | 137 | 232 | -358 | -67.3 | -239 | -336 | -93.6 | -14.2 | -247 | 152 | -30.6 |